CIK 0001677940 · Non-accelerated filer<br>Smaller reporting company
BeyondSpring Inc.
Sign in to watch- Ticker
- BYSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 646-528-4184
- Business address
- 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, SUITE 410, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Majeti Jiangwen Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2026-07-01 | Qiu Min Chief Executive Officer | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2026-04-01 | Kirkby Matthew Director | Grant or award · Stock Options (right to buy) | +23,902 | 23,902 | ||
| 2026-04-01 | Fabbio Patrick Director | Grant or award · Stock Options (right to buy) | +22,165 | 22,165 | ||
| 2026-04-01 | Delaney Brendan Director | Grant or award · Stock Options (right to buy) | +20,427 | 20,427 | ||
| 2026-04-01 | Majeti Jiangwen Director | Grant or award · Stock Options (right to buy) | +21,730 | 21,730 | ||
| 2026-04-01 | Lu Yingjuan June Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +17,840 | 17,840 | ||
| 2026-04-01 | Huang Lan Chief Executive Officer | Grant or award · Stock Options (right to buy) | +11,514 | 11,514 | ||
| 2026-04-01 | Xu Sihai Director | Grant or award · Stock Options (right to buy) | +18,689 | 18,689 | ||
| 2026-03-20 | Huang Lan Chief Executive Officer | Gift | −260,582 | 0 | ||
| 2025-10-17 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −45,513 | $1.76 | $80K | 1,518,893 |
| 2025-10-16 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −85,798 | $1.72 | $148K | 1,564,406 |
| 2025-10-15 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −17,960 | $1.65 | $30K | 1,650,204 |
| 2025-10-14 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −28,495 | $1.65 | $47K | 1,668,164 |
| 2025-10-13 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −107,361 | $1.70 | $183K | 1,696,659 |
| 2025-10-10 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −2,390 | $1.77 | $4K | 1,804,020 |
| 2025-10-09 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −3,979 | $1.81 | $7K | 1,806,410 |
| 2025-10-08 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −7,507 | $1.77 | $13K | 1,810,389 |
| 2025-10-07 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −2,100 | $1.79 | $4K | 1,817,896 |
| 2025-10-06 | Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner | Sale | −17,500 | $1.78 | $31K | 1,819,996 |
Page 1 of 4 · 80 trades